VP, Biopharmaceutical Development and Manufacturing @ (April 2019 - December 2021)
VP, Bioprocess and Analytical Development @ (October 2017 - April 2019)
Vice President, Bioprocess Development and Manufacturing @ Crestovo (August 2016 - October 2017)
Director, Analytical Development and Formulations @ (March 2013 - August 2016)
Associate Director-Formulation and Analytical @ (January 2010 - January 2013)
Senior Scientist @ (January 2009 - January 2010)
Scientist @ Formatech (January 2006 - January 2009)
Post Doc @ (January 2000 - January 2006)
Post Doc @ University of Texas at Galveston (January 1998 - January 2000)
PHD Student @ Institute of Miicrobial Technology (January 1993 - January 1998)
Graduate Student @ (January 1993 - January 1998)
Masters Student @ (January 1991 - January 1993)
Bharat Dixit Education
Sam Houston State University
Bachelor Of Applied Science (Construction Management)
2012-2016
Sam Houston State University 2012-2015
Bharat Dixit Skills
Molecular Biology
Analytical Chemistry
Lifesciences
Protein Purification
Assay Development
Biotechnology
Cell
Biochemistry
Pharmaceutical Industry
Immunology
Life Sciences
Cell Culture
Cell Biology
ELISA
Fluorescence Microscopy
Western Blotting
Protein Chemistry
Vaccines
Antibodies
PowerPoint
AutoCAD
Carpentry
Team Management
Microsoft Word
Construction
Microsoft Excel
Social Networking
Customer Service
Teamwork
Bharat Dixit Summary
Bharat Dixit, based in Boston, MA, US, is currently a Chief Technology Officer at Adiso Therapeutics. Bharat Dixit brings experience from previous roles at ClearB Therapeutics, Artugen Therapeutics, Finch Therapeutics Group and Crestovo. Bharat Dixit holds a 2012 - 2016 Bachelor Of Applied Science in Construction Management @ Sam Houston State University. With a robust skill set that includes Molecular Biology, Analytical Chemistry, Lifesciences, Protein Purification, Assay Development and more. Bharat Dixit has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Bharat Dixit?
Find contact details for 700 million professionals.